Stay updated on Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial
Sign up to get notified when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.

Latest updates to the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study record page now displays a 403 Forbidden error, indicating access to the content is blocked. This replaces the typical study details with an access-denied notice rather than updating core content.SummaryDifference23%

- Check19 days agoChange DetectedThe study page text remains unchanged. Observed differences appear to be visual/layout updates that do not affect the core study details or results.SummaryDifference0.1%

- Check26 days agoChange DetectedThere are no recorded changes to the page content; the study details page remains unchanged.SummaryDifference0.1%

- Check34 days agoChange DetectedA new note indicates 2018 NIH grant/contract funding was added, and the page revision tag was updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded study documents to the Study Documents section, including Phase I and Phase II study protocols, the Statistical Analysis Plan, and the IPD sharing plan. These entries include provider notes and access information, expanding transparency and access to the trial's methodological materials.SummaryDifference100%

- Check55 days agoChange DetectedPage revision updated to v3.6.5, indicating a minor patch to the interface. This change does not modify the study details or content presented on the page.SummaryDifference0.1%

Stay in the know with updates to Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.